Acumen Pharmaceuticals, Inc. (ABOS) vs LifeMD, Inc. (LFMDP)
A side-by-side comparison of Acumen Pharmaceuticals, Inc. and LifeMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABOS
Acumen Pharmaceuticals, Inc.
$2.00HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
LFMDP
LifeMD, Inc.
$21.70HealthcareDelayed quote: Oct 6, 2026, 10:34 AM EDT
Total return — ABOS vs LFMDP
growth of $100 · dividends reinvested · last 5yABOS -86.1% (-32.6%/yr)LFMDP +67.0% (+10.8%/yr)LFMDP compounded faster over this window
Log scale — wide-divergence pair
ABOS LFMDP
ABOS vs LFMDP: by the numbers
- •LFMDP is the larger company ($148M vs $144M market cap).
- •Both run net losses; ABOS's is the smaller (0.00% vs -10.40% net margin).
- •LFMDP pays a dividend (9.71% yield), while ABOS has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | ABOS | LFMDP |
|---|---|---|
| P/S ratio | N/A | 0.72 |
| P/B ratio | 2.52 | 18.57 |
Profitability
| Metric | ABOS | LFMDP |
|---|---|---|
| Gross margin | 0.00% | 85.91% |
| Operating margin | 0.00% | -9.35% |
| Net margin | 0.00% | -10.40% |
| ROE | -183.44% | -266.86% |
| ROIC | -118.67% | -143.97% |
Dividends
| Metric | ABOS | LFMDP |
|---|---|---|
| Dividend yield | N/A | 9.71% |
Growth (annualized)
| Metric | ABOS | LFMDP |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 26.00% |
| Total return CAGR (5Y) | -32.60% | 10.80% |
Frequently asked
- Does ABOS or LFMDP pay a bigger dividend?
- LFMDP pays a dividend (9.71% yield), while ABOS has no payments in the available dividend history.
- How have ABOS and LFMDP total returns compared?
- Over the past 5 years, ABOS delivered -32.60% and LFMDP delivered 10.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
LifeMD dividend yieldAcumen Pharmaceuticals ROELifeMD ROEAcumen Pharmaceuticals operating marginLifeMD operating marginAcumen Pharmaceuticals revenue growthLifeMD revenue growthAcumen Pharmaceuticals free cash flowLifeMD free cash flow
Acumen Pharmaceuticals & LifeMD appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.